Acute kidney injury (AKI) causes a lot of harm to human health but is treated by only
supportive therapy in most cases. Recent evidence shows that mesenchymal stem cells …

Cell‐to‐cell communication and information exchange is one of the most important events in
multiple physiological processes, including multicellular organism development, cellular …

Mesenchymal stem cells are currently considered as a promising tool for therapeutic
application in acute kidney injury (AKI) management. AKI is characterized by acute tubular …

Background: Acute kidney injury (AKI) is a multifaced disease characterized by a rapid
decline in renal function. However, with growing insight into the pathophysiologic …

Acute kidney injury (AKI) is classically described as a rapid loss of kidney function. AKI
affects more than 15% of all hospital admissions and is associated with elevated mortality …

Acute kidney injury (AKI) and chronic kidney disease (CKD) are rising in global prevalence
and cause significant morbidity for patients. Current treatments are limited to slowing instead …

The potential role of mesenchymal stem cells (MSCs, also called mesenchymal stromal
cells) in endogenous repair and cell-based therapies for acute kidney injury (AKI) is under …

Acute kidney injury (AKI) is a frequent clinical disease with a high morbidity rate and
mortality rate, while the treatment options for this intractable disease are limited currently. In …

Kidney diseases pose a threat to human health due to their rising incidence and fatality rate.
In preclinical and clinical studies, it has been acknowledged that mesenchymal stem cells …

Acute kidney injury (AKI) is a common and potential life-threatening disease in patients
admitted to hospital, affecting 10%–15% of all hospitalizations and around 50% of patients …